top of page

Women in Psychedelic Science - Part 4

This is the full recording of our 4th Women in Psychedelic Science event, hosted in June. Featuring experts working at the cutting edge of psychedelic science and in related fieldwork.

Psychedelic medicine: from lab findings to therapeutic applications

Dr Kim Kuypers
Kim PC Kuypers (PhD) is affiliated as an Associate Professor with Maastricht University, Faculty of Psychology and Neuroscience, where she obtained her Ph.D. in 2003. Her main goal is to understand the neurobiology underlying flexible cognition, empathy, and well-being. To accomplish this, she uses a psychopharmacological model to induce (sub)acute and longer-lasting effects on the behavior mentioned above with psychedelics and investigate the underlying biology. She also conducts survey research to understand the motives underlying psychedelic use and the experienced effects. She develops new paradigms to study cognitive flexibility and empathy in a more ecologically valid way. The survey research gives direction to her experimental research in which she uses the newly developed paradigms. Her research contributes to understanding the biological and psychological underpinnings of cognitive and emotional processes linked to well-being.

Ayahuasca and Depression

Dr Fernanda Palhano-Fontes
Fernanda has been studying the psychedelic ayahusaca since 2010. She holds a Master’s and PhD in Neurosciences from the Brain Institute of UFRN. During her masters, she used functional magnetic resonance imaging (fMRI) to evaluate the acute effects of ayahuasca in healthy individuals. She went on to investigate the therapeutic potential of ayahuasca in patients with treatment-resistant depression for her PhD these.

Depth Relational Process: An Integrative Approach

Maria Papaspyrou
Maria Papaspyrou is an integrative psychotherapist, clinical supervisor and family constellations practitioner based in Brighton UK. She has worked for over twenty years in the fields of mental health, trauma and education and in the last decade she has been specialising in psychedelic integration. She is the co-founder and co-director of the Institute of Psychedelic Therapy (IPT), part of the wider team in Breaking Convention, the co-editor of “Psychedelic Mysteries of the Feminine” (Park Street Press, 2019) and the co-editor of “Psychedelics and Psychotherapy: The Healing Potential of Expanded States” (Park Street Press, September 2021).

50 Years of Psychedelic Research

Amanda Feilding, Countess of Wemyss and March
Amanda has dedicated over 50 years to the scientific exploration of psychedelics in the belief that modern science can be used to understand, validate, and optimise the healing potential of psychedelic medicines. She has been dubbed “the hidden hand” behind the renaissance in psychedelic science, and in 1998, she set up the Beckley Foundation in order to open up the doors of scientific research into the potential benefits of psychedelics. The Beckley Foundation works to develop a scientific evidence base to help reform global drug policies, so that these compounds can be made available to patients in need.

The Shifting Tides of Psychedelic Policy

Serena Wu
Serena is a co-founding partner of Plant Medicine Law Group, a law firm focused on psychedelics and cannabis law. She is a strong proponent of safe, legal and equitable access to plant medicine

Developing a traditional medicine strategy for the Diabetes epidemic in First Nations communities

Jazmin Pirozek
Jazmin is a consultant developing a traditional medicine strategy for the Diabetes epidemic in the First Nations communities in Canada. She received her master’s degree in Biology, focussing on Boreal Forest Ethnobotany, and is a student of Maestro Juan Flores, a Plant Medicine Teacher of the Peruvian Amazon.

Drug Science is the leading independent scientific body on drugs in the UK. We rely on donations to provide clear, evidence-based information without political or commercial interference. Drug Science webinars are free, so if you’d like to support us then please consider joining the Drug Science Community.

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

bottom of page